Active RNAP pre-initiation sites are highly mutated by cytidine deaminases in yeast, with AID targeting small RNA genes.

Elife

Protein and Nucleic Acid Chemistry Division, Medical Research Council Laboratory of Molecular Biology, Cambridge, United Kingdom.

Published: September 2014

Cytidine deaminases are single stranded DNA mutators diversifying antibodies and restricting viral infection. Improper access to the genome leads to translocations and mutations in B cells and contributes to the mutation landscape in cancer, such as kataegis. It remains unclear how deaminases access double stranded genomes and whether off-target mutations favor certain loci, although transcription and opportunistic access during DNA repair are thought to play a role. In yeast, AID and the catalytic domain of APOBEC3G preferentially mutate transcriptionally active genes within narrow regions, 110 base pairs in width, fixed at RNA polymerase initiation sites. Unlike APOBEC3G, AID shows enhanced mutational preference for small RNA genes (tRNAs, snoRNAs and snRNAs) suggesting a putative role for RNA in its recruitment. We uncover the high affinity of the deaminases for the single stranded DNA exposed by initiating RNA polymerases (a DNA configuration reproduced at stalled polymerases) without a requirement for specific cofactors.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359381PMC
http://dx.doi.org/10.7554/eLife.03553DOI Listing

Publication Analysis

Top Keywords

cytidine deaminases
8
yeast aid
8
small rna
8
rna genes
8
deaminases single
8
single stranded
8
stranded dna
8
rna
5
active rnap
4
rnap pre-initiation
4

Similar Publications

Low Bacterial Biomass in Human Pancreatic Cancer and Adjacent Normal Tissue.

Int J Mol Sci

December 2024

Department of Medicine, Vagelos College of Physicians & Surgeons, Columbia University, 630 West 168th Street, New York, NY 10032, USA.

The gut microbiome plays an important role in the carcinogenesis of luminal gastrointestinal malignancies and response to antineoplastic therapy. Preclinical studies have suggested a role of intratumoral gammaproteobacteria in mediating response to gemcitabine-based chemotherapy in pancreatic ductal adenocarcinoma (PDAC). To our knowledge, this is the first study to evaluate the impact of the PDAC microbiome on chemotherapy response using samples from human pancreatic tumor resections.

View Article and Find Full Text PDF

CAG/CTG repeats are prone to expansion, causing several inherited human diseases. The initiating sources of DNA damage which lead to inaccurate repair of the repeat tract to cause expansions are not fully understood. Expansion-prone CAG/CTG repeats are actively transcribed and prone to forming stable R-loops with hairpin structures forming on the displaced single-stranded DNA (S-loops).

View Article and Find Full Text PDF

Untargeted Mutation Triggered by Ribonucleoside Embedded in DNA.

Int J Mol Sci

December 2024

Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan.

DNA polymerases frequently misincorporate ribonucleoside 5'-triphosphates into nascent DNA strands. This study examined the effects of an incorporated ribonucleoside on untargeted mutations in human cells. Riboguanosine (rG) was introduced into the downstream region of the gene to preferentially detect the untargeted mutations.

View Article and Find Full Text PDF

Viral infection, APOBEC3 dysregulation, and cancer.

Front Genet

December 2024

Host-Pathogen Interaction Program, Texas Biomedical Research Institute, San Antonio, TX, United States.

Viral infection plays a significant role in the development and progression of many cancers. Certain viruses, such as Human Papillomavirus (HPV), Epstein-Barr Virus (EBV), and Hepatitis B and C viruses (HBV, HCV), are well-known for their oncogenic potential. These viruses can dysregulate specific molecular and cellular processes through complex interactions with host cellular mechanisms.

View Article and Find Full Text PDF

Development and optimization of a high-throughput HPLC-MS/MS method for the simultaneous determination of Cedazuridine, Gemcitabine and its metabolite in mouse plasma.

J Chromatogr B Analyt Technol Biomed Life Sci

December 2024

Department of Pharmaceutical Analysis, Wuya College of Innovation, Shenyang Pharmaceutical University, No. 103, Wenhua Road, Shenyang 110016, China. Electronic address:

Article Synopsis
  • Gemcitabine (GEM) is widely used to treat solid tumors, but its effectiveness is limited by rapid metabolism into an inactive form (dFdU) by the enzyme cytidine deaminase (CDA), which decreases its oral bioavailability.
  • Cedazuridine (CDZ) has been identified as a potent inhibitor of CDA, and when combined with GEM, it may enhance GEM's oral bioavailability.
  • A study using HPLC-MS/MS confirmed that CDZ significantly improved GEM's bioavailability in mice by inhibiting its metabolism, suggesting potential benefits for clinical applications of the GEM-CDZ combination.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!